Literature DB >> 18990314

Treatment of acute intracerebral hemorrhage.

Bart M Demaerschalk1, Maria I Aguilar.   

Abstract

Intracerebral hemorrhage (ICH) is a neurologic emergency associated with regular, early, ongoing hemorrhage, progressive clinical deterioration, severe deficits, and high mortality. Hence, it requires prompt recognition, diagnosis, and management. Initial monitoring and management of patients with ICH should occur in an intensive care unit. The overall approach to treatment mandates using therapies to stop or slow the initial bleeding acutely, removing blood from the parenchyma or ventricles (in eligible patients) to prevent secondary brain injury, addressing raised intracranial pressure, and providing good, comprehensive supportive care, including management of airways, oxygenation, blood pressure, circulation, glucose level, fever, and nutrition, as well as deep venous thrombosis prophylaxis.

Entities:  

Year:  2008        PMID: 18990314     DOI: 10.1007/s11940-008-0048-3

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  47 in total

1.  Fibrinolytic therapy for intraventricular hemorrhage: is the answer becoming clear yet?

Authors:  B M Demaerschalk
Journal:  Eur J Neurol       Date:  2008-04       Impact factor: 6.089

2.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

3.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

Review 4.  Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.

Authors:  Maria I Aguilar; Robert G Hart; Carlos S Kase; William D Freeman; Barbara J Hoeben; Rosa C García; Jack E Ansell; Stephan A Mayer; Bo Norrving; Jonathan Rosand; Thorsten Steiner; Eelco F M Wijdicks; Takenori Yamaguchi; Masahiro Yasaka
Journal:  Mayo Clin Proc       Date:  2007-01       Impact factor: 7.616

5.  Cerebellar haemorrhage: management and prognosis.

Authors:  R Firsching; M Huber; R A Frowein
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

6.  Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases.

Authors:  R Da Pian; A Bazzan; A Pasqualin
Journal:  Neurol Res       Date:  1984-09       Impact factor: 2.448

7.  Early edema in warfarin-related intracerebral hemorrhage.

Authors:  Joshua M Levine; Ryan Snider; David Finkelstein; Mahmut E Gurol; Rishi Chanderraj; Eric E Smith; Steven M Greenberg; Jonathan Rosand
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 8.  Intracerebral hemorrhage.

Authors:  Maria I Aguilar; Bart M Demaerschalk
Journal:  Semin Neurol       Date:  2007-09       Impact factor: 3.420

9.  Modern treatment options for intracerebral hemorrhage.

Authors:  William D Freeman; Thomas G Brott
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.598

10.  Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial.

Authors:  Julio Cruz; Giulio Minoja; Kazuo Okuchi
Journal:  Neurosurgery       Date:  2002-09       Impact factor: 4.654

View more
  1 in total

1.  Treatment of coagulopathy in intracranial hemorrhage.

Authors:  Maria I Aguilar; William D Freeman
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.